• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    8/2/23 1:55:33 PM ET
    $RDHL
    $RDWR
    $SILV
    $SNES
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate
    Real Estate
    Get the next $RDHL alert in real time by email

     

    During Wednesday's trading, 103 companies set new 52-week lows.

    Interesting Facts About Today's 52-Week Lows:

    • Estee Lauder Cos (NYSE:EL) was the biggest company in terms of market cap to set a new 52-week low.
    • Esports Entertainment (NASDAQ:GMBL) was the smallest company in terms of market cap to set a new 52-week low.
    • ExlService Holdings (NASDAQ:EXLS)'s stock moved significantly downwards, trading down 80.66% to reach a new 52-week low.
    • IDT (NYSE:IDT) saw the biggest bounce back on, as shares traded up 0.04% to rebound after it hit its new 52-week low.

    The following stocks created new 52-week lows on Wednesday:

    • Estee Lauder Cos (NYSE:EL) stock drifted down 1.97% on Wednesday morning to hit a new 52-week low of $170.90.
    • Moderna (NASDAQ:MRNA) shares hit a yearly low of $110.84. The stock was down 2.27% on the session.
    • TELUS (NYSE:TU) shares set a new yearly low of $17.32 this morning. The stock was down 2.17% on the session.
    • Enphase Energy (NASDAQ:ENPH) stock drifted down 5.9% on Wednesday morning to hit a new 52-week low of $140.28.
    • ZoomInfo Technologies (NASDAQ:ZI) shares reached a new 52-week low of $18.31 on Wednesday morning, moving down 0.59%.
    • Agree Realty (NYSE:ADC) stock dropped to a yearly low on Wednesday of $62.79. Shares traded down 2.8%.
    • ExlService Holdings (NASDAQ:EXLS) stock dropped to a yearly low on Wednesday of $27.22. Shares traded down 80.66%.
    • PNM Resources (NYSE:PNM) stock set a new 52-week low of $44.30 on Wednesday, moving down 0.39%.
    • Insperity (NYSE:NSP) shares hit a yearly low of $94.00. The stock was down 3.56% on the session.
    • Spire (NYSE:SR) stock hit $59.49 on Wednesday morning, setting a new 52-week low for a change of down 3.4%.
    • NovoCure (NASDAQ:NVCR) stock drifted down 6.98% on Wednesday morning to hit a new 52-week low of $30.21.
    • Cytokinetics (NASDAQ:CYTK) stock achieved a new 52-week low on Wednesday morning, hitting $31.46 and moving down 1.54%.
    • Clearway Energy (NYSE:CWEN) shares set a new 52-week low of $25.17. The stock traded down 2.48%.
    • National Storage (NYSE:NSA) shares fell to $32.80 on Wednesday, setting a new 52-week low with a shift of down 0.8%.
    • Apellis Pharmaceuticals (NASDAQ:APLS) stock set a new 52-week low of $22.73 on Wednesday, moving down 4.91%.
    • Sensient Technologies (NYSE:SXT) stock broke to a new 52-week low of $62.64 on Wednesday. Shares of the company traded down 1.48%.
    • TELUS Intl (NYSE:TIXT) shares fell to $8.74 on Wednesday, setting a new 52-week low with a shift of down 3.41%.
    • Driven Brands Hldgs (NASDAQ:DRVN) stock hit a new 52-week low of $13.15. The stock was down 48.68% on the session.
    • Beam Therapeutics (NASDAQ:BEAM) shares set a new yearly low of $27.46 this morning. The stock was down 1.86% on the session.
    • Perficient (NASDAQ:PRFT) stock dropped to a yearly low on Wednesday of $58.94. Shares traded down 2.74%.
    • Impinj (NASDAQ:PI) stock drifted down 4.11% on Wednesday morning to hit a new 52-week low of $62.44.
    • Pacira BioSciences (NASDAQ:PCRX) shares fell to $34.08 on Wednesday, setting a new 52-week low with a shift of up 0.64%.
    • SunPower (NASDAQ:SPWR) stock broke to a new 52-week low of $8.94 on Wednesday. Shares of the company traded down 8.99%.
    • Maravai LifeSciences (NASDAQ:MRVI) shares fell to $10.78 on Wednesday, setting a new 52-week low with a shift of up 4.94%.
    • Duckhorn Portfolio (NYSE:NAPA) shares were down 0.12% for the day, having made a 52-week low of $12.35.
    • Nu Skin Enterprises (NYSE:NUS) shares hit a yearly low of $27.50. The stock was down 6.29% on the session.
    • BioCryst Pharma (NASDAQ:BCRX) stock hit a yearly low of $6.78. The stock was down 0.22% for the day.
    • Horace Mann Educators (NYSE:HMN) stock broke to a new 52-week low of $28.15 on Wednesday. Shares of the company traded down 5.68%.
    • Monro (NASDAQ:MNRO) stock broke to a new 52-week low of $34.94 on Wednesday. Shares of the company traded down 2.34%.
    • Hain Celestial Group (NASDAQ:HAIN) stock broke to a new 52-week low of $11.50 on Wednesday. Shares of the company traded down 2.59%.
    • Infinera (NASDAQ:INFN) stock hit a yearly low of $4.22. The stock was down 2.19% for the day.
    • Suburban Propane Partners (NYSE:SPH) stock broke to a new 52-week low of $14.42 on Wednesday. Shares of the company traded down 0.96%.
    • IntL Money Express (NASDAQ:IMXI) stock hit a yearly low of $19.31. The stock was down 16.84% for the day.
    • Radware (NASDAQ:RDWR) shares set a new yearly low of $14.96 this morning. The stock was down 15.39% on the session.
    • Nevro (NYSE:NVRO) shares set a new yearly low of $18.55 this morning. The stock was down 23.88% on the session.
    • SilverCrest Metals (AMEX:SILV) stock dropped to a yearly low on Wednesday of $4.16. Shares traded down 6.15%.
    • IDT (NYSE:IDT) shares fell to $22.76 on Wednesday, setting a new 52-week low with a shift of up 0.04%.
    • Anterix (NASDAQ:ATEX) stock hit a yearly low of $27.20. The stock was up 2.05% for the day.
    • ModivCare (NASDAQ:MODV) shares set a new 52-week low of $35.68. The stock traded down 2.0%.
    • Beneficient (NASDAQ:BENF) shares set a new yearly low of $1.80 this morning. The stock was down 6.5% on the session.
    • Artesian Resources (NASDAQ:ARTNA) shares fell to $45.01 on Wednesday, setting a new 52-week low with a shift of up 0.53%.
    • Fate Therapeutics (NASDAQ:FATE) stock achieved a new 52-week low on Wednesday morning, hitting $3.73 and moving down 4.79%.
    • 2seventy bio (NASDAQ:TSVT) shares moved down 3.03% on Wednesday to hit a new 52-week low of $6.63, drifting down 3.03%.
    • PSQ Holdings (NYSE:PSQH) shares hit a yearly low of $11.57. The stock was down 6.55% on the session.
    • Cambium Networks (NASDAQ:CMBM) shares were down 37.64% for the day, having made a 52-week low of $8.84.
    • BRC (NYSE:BRCC) stock hit a new 52-week low of $4.21. The stock was down 4.39% on the session.
    • TPI Composites (NASDAQ:TPIC) shares moved down 0.78% on Wednesday to hit a new 52-week low of $5.53, drifting down 0.78%.
    • Gold Royalty (AMEX:GROY) stock hit $1.65 on Wednesday morning, setting a new 52-week low for a change of down 4.6%.
    • Nuveen Virginia Quality (NYSE:NPV) stock drifted down 0.92% on Wednesday morning to hit a new 52-week low of $10.60.
    • Orchestra BioMed Hldgs (NASDAQ:OBIO) shares set a new 52-week low of $5.19. The stock traded down 4.0%.
    • Prelude Therapeutics (NASDAQ:PRLD) shares were down 2.71% for the day, having made a 52-week low of $3.56.
    • NGM Biopharmaceuticals (NASDAQ:NGM) shares moved down 1.98% on Wednesday to hit a new 52-week low of $2.16, drifting down 1.98%.
    • Inogen (NASDAQ:INGN) shares set a new 52-week low of $7.54. The stock traded down 3.55%.
    • Akoustis Technologies (NASDAQ:AKTS) shares moved down 2.56% on Wednesday to hit a new 52-week low of $2.26, drifting down 2.56%.
    • Complete Solaria (NASDAQ:CSLR) shares hit a yearly low of $3.14. The stock was down 5.0% on the session.
    • Electrovaya (NASDAQ:ELVA) stock set a new 52-week low of $4.05 on Wednesday, moving up 4.1%.
    • Zevia (NYSE:ZVIA) stock dropped to a yearly low on Wednesday of $2.65. Shares traded down 2.36%.
    • Platinum Gr Metals (AMEX:PLG) shares set a new yearly low of $1.27 this morning. The stock was down 4.51% on the session.
    • Loop Media (AMEX:LPTV) stock hit a yearly low of $2.13. The stock was down 3.59% for the day.
    • G1 Therapeutics (NASDAQ:GTHX) shares set a new 52-week low of $2.11. The stock traded up 0.68%.
    • PaySign (NASDAQ:PAYS) shares fell to $1.82 on Wednesday, setting a new 52-week low with a shift of down 3.19%.
    • Byrna Technologies (NASDAQ:BYRN) shares were down 3.14% for the day, having made a 52-week low of $3.30.
    • TD Hldgs (NASDAQ:GLG) shares hit a yearly low of $0.47. The stock was down 2.69% on the session.
    • Ohmyhome (NASDAQ:OMH) shares were down 0.94% for the day, having made a 52-week low of $2.72.
    • Zapp Electric Vehicles (NASDAQ:ZAPP) shares made a new 52-week low of $1.40 on Wednesday. The stock was down 4.7% for the day.
    • AquaBounty Techs (NASDAQ:AQB) stock hit $0.31 on Wednesday morning, setting a new 52-week low for a change of down 9.97%.
    • Phoenix New Media (NYSE:FENG) stock achieved a new 52-week low on Wednesday morning, hitting $1.61 and moving up 1.2%.
    • Cosmos Health (NASDAQ:COSM) stock achieved a new 52-week low on Wednesday morning, hitting $1.35 and moving down 4.08%.
    • Polished.com (AMEX:POL) stock hit a new 52-week low of $0.17. The stock was down 13.61% on the session.
    • ShiftPixy (NASDAQ:PIXY) stock hit a new 52-week low of $1.01. The stock was down 7.21% on the session.
    • Treasure Global (NASDAQ:TGL) stock hit a new 52-week low of $0.65. The stock was down 6.3% on the session.
    • Tonix Pharmaceuticals (NASDAQ:TNXP) shares moved down 2.43% on Wednesday to hit a new 52-week low of $0.99, drifting down 2.43%.
    • Biophytis (NASDAQ:BPTS) shares were down 1.16% for the day, having made a 52-week low of $1.67.
    • Taoping (NASDAQ:TAOP) stock drifted down 13.12% on Wednesday morning to hit a new 52-week low of $4.11.
    • Yoshiharu Global (NASDAQ:YOSH) shares were down 4.96% for the day, having made a 52-week low of $0.51.
    • Universe Pharmaceuticals (NASDAQ:UPC) stock hit a new 52-week low of $1.68. The stock was down 8.68% on the session.
    • Redhill Biopharma (NASDAQ:RDHL) stock broke to a new 52-week low of $1.15 on Wednesday. Shares of the company traded down 7.2%.
    • Biolase (NASDAQ:BIOL) stock dropped to a yearly low on Wednesday of $5.11. Shares traded down 8.89%.
    • Synaptogenix (NASDAQ:SNPX) shares made a new 52-week low of $0.67 on Wednesday. The stock was down 8.51% for the day.
    • Phio Pharma (NASDAQ:PHIO) shares fell to $2.53 on Wednesday, setting a new 52-week low with a shift of down 2.99%.
    • NanoVibronix (NASDAQ:NAOV) shares moved down 5.37% on Wednesday to hit a new 52-week low of $2.82, drifting down 5.37%.
    • Digital Brands Group (NASDAQ:DBGI) shares set a new yearly low of $0.55 this morning. The stock was up 1.26% on the session.
    • Aptevo Therapeutics (NASDAQ:APVO) stock hit a yearly low of $0.58. The stock was down 39.89% for the day.
    • Intelligent Bio Solutions (NASDAQ:INBS) shares set a new 52-week low of $1.71. The stock traded down 1.21%.
    • Adamis Pharmaceuticals (NASDAQ:ADMP) shares set a new 52-week low of $1.28. The stock traded down 63.91%.
    • Ault Alliance (AMEX:AULT) shares set a new yearly low of $2.61 this morning. The stock was down 8.36% on the session.
    • Oblong (NASDAQ:OBLG) stock achieved a new 52-week low on Wednesday morning, hitting $1.22 and moving down 1.6%.
    • SenesTech (NASDAQ:SNES) shares were down 1.1% for the day, having made a 52-week low of $0.88.
    • NeuBase Therapeutics (NASDAQ:NBSE) stock achieved a new 52-week low on Wednesday morning, hitting $1.20 and moving down 1.55%.
    • Akanda (NASDAQ:AKAN) shares fell to $0.58 on Wednesday, setting a new 52-week low with a shift of down 3.78%.
    • Allarity Therapeutics (NASDAQ:ALLR) shares reached a new 52-week low of $2.24 on Wednesday morning, moving down 8.03%.
    • Esports Entertainment (NASDAQ:GMBL) stock dropped to a yearly low on Wednesday of $0.33. Shares traded down 13.88%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $RDHL alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RDHL
    $RDWR
    $SILV
    $SNES

    CompanyDatePrice TargetRatingAnalyst
    Estee Lauder Companies Inc.
    $EL
    10/31/2025$99.00 → $105.00Market Perform
    Telsey Advisory Group
    Fate Therapeutics Inc.
    $FATE
    10/31/2025$5.00Neutral → Buy
    H.C. Wainwright
    Spire Inc.
    $SR
    10/29/2025$89.00Underperform → Neutral
    BofA Securities
    Enphase Energy Inc.
    $ENPH
    10/29/2025$40.00 → $35.00Hold
    TD Cowen
    Fate Therapeutics Inc.
    $FATE
    10/27/2025$7.00Neutral → Outperform
    Wedbush
    Enphase Energy Inc.
    $ENPH
    10/23/2025$37.00Outperform → Neutral
    Mizuho
    Spire Inc.
    $SR
    10/22/2025$99.00Buy
    BTIG Research
    BioCryst Pharmaceuticals Inc.
    $BCRX
    10/15/2025$30.00Buy
    TD Cowen
    More analyst ratings

    $RDHL
    $RDWR
    $SILV
    $SNES
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Blum Robert I gifted 2,000 shares, decreasing direct ownership by 0.56% to 356,108 units (SEC Form 4)

    4 - CYTOKINETICS INC (0001061983) (Issuer)

    11/5/25 4:22:20 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VP and Treasurer Plautz David J. bought $199,907 worth of shares (2,150 units at $92.98), increasing direct ownership by 253% to 2,999 units (SEC Form 4)

    4 - SENSIENT TECHNOLOGIES CORP (0000310142) (Issuer)

    11/5/25 2:48:34 PM ET
    $SXT
    Major Chemicals
    Industrials

    President & CEO Zuraitis Marita sold $220,865 worth of shares (5,000 units at $44.17), decreasing direct ownership by 2% to 288,788 units (SEC Form 4)

    4 - HORACE MANN EDUCATORS CORP /DE/ (0000850141) (Issuer)

    11/5/25 11:23:15 AM ET
    $HMN
    Property-Casualty Insurers
    Finance

    $RDHL
    $RDWR
    $SILV
    $SNES
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Estee Lauder with a new price target

    Telsey Advisory Group reiterated coverage of Estee Lauder with a rating of Market Perform and set a new price target of $105.00 from $99.00 previously

    10/31/25 8:41:15 AM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Fate Therapeutics upgraded by H.C. Wainwright with a new price target

    H.C. Wainwright upgraded Fate Therapeutics from Neutral to Buy and set a new price target of $5.00

    10/31/25 8:14:08 AM ET
    $FATE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Spire upgraded by BofA Securities with a new price target

    BofA Securities upgraded Spire from Underperform to Neutral and set a new price target of $89.00

    10/29/25 7:50:30 AM ET
    $SR
    Oil/Gas Transmission
    Utilities

    $RDHL
    $RDWR
    $SILV
    $SNES
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP and Treasurer Plautz David J. bought $199,907 worth of shares (2,150 units at $92.98), increasing direct ownership by 253% to 2,999 units (SEC Form 4)

    4 - SENSIENT TECHNOLOGIES CORP (0000310142) (Issuer)

    11/5/25 2:48:34 PM ET
    $SXT
    Major Chemicals
    Industrials

    Large owner Icahn Carl C bought $9,713,595 worth of shares (639,473 units at $15.19) (SEC Form 4)

    4 - MONRO, INC. (0000876427) (Issuer)

    11/5/25 8:00:59 AM ET
    $MNRO
    Automotive Aftermarket
    Consumer Discretionary

    President & CEO Kothandaraman Badrinarayanan bought $309,317 worth of shares (10,000 units at $30.93) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    11/3/25 5:08:01 PM ET
    $ENPH
    Semiconductors
    Technology

    $RDHL
    $RDWR
    $SILV
    $SNES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Zevia Announces Third Quarter 2025 Results

    Q3 Net Sales Up 12.3%, led by volume growth Exceeds Net Sales and Adj. EBITDA guidance Zevia PBC ("Zevia" or the "Company") (NYSE:ZVIA), the Company bringing naturally delicious, zero sugar, clean-label beverages, today reported results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Net sales grew 12.3% to $40.8 million Gross profit margin was 45.6%, a reduction of 3.5 percentage points year over year Net loss was $2.8 million, including $0.9 million of non-cash equity-based compensation expense Loss per share was $0.04 to Zevia's Class A Common stockholders Adjusted EBITDA loss of $1.7 million(1) "Our strong performance in the third quarter, hi

    11/5/25 4:05:00 PM ET
    $ZVIA
    Beverages (Production/Distribution)
    Consumer Staples

    Cytokinetics Reports Third Quarter 2025 Financial Results and Provides Business Update

    Interactions with FDA Progressing Towards December 26, 2025 PDUFA Date for Aficamten; U.S. Commercial Launch Preparations on Track Ex-U.S. Regulatory Reviews of Aficamten Ongoing in China and E.U. ~$1.25 Billion in Cash, Cash Equivalents and Investments as of September 30, 2025 SOUTH SAN FRANCISCO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) reported a management update and financial results for the third quarter of 2025. "I'm pleased that our teams continue to demonstrate strong execution and sustained momentum as we approach the PDUFA date for the aficamten NDA. Our commercial preparations have been deliberate and strategic, positioning us well

    11/5/25 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Beneficient Statement About Brad Heppner Indictment

    DALLAS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) (the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today issued a statement about the United States Attorney for the Southern District of New York's recent indictment of the Company's former Chairman and CEO, Brad Heppner. As previously disclosed, Beneficent parted ways with Mr. Heppner earlier this year promptly after the Company learned of clear and credible evidence of his fraud on the Company and others. Beneficient will continue to vigorously

    11/5/25 9:00:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    $RDHL
    $RDWR
    $SILV
    $SNES
    SEC Filings

    View All

    SEC Form 10-Q filed by Driven Brands Holdings Inc.

    10-Q - Driven Brands Holdings Inc. (0001804745) (Filer)

    11/5/25 5:13:33 PM ET
    $DRVN
    Automotive Aftermarket
    Consumer Discretionary

    SEC Form 10-Q filed by Cytokinetics Incorporated

    10-Q - CYTOKINETICS INC (0001061983) (Filer)

    11/5/25 4:31:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Zevia PBC

    10-Q - Zevia PBC (0001854139) (Filer)

    11/5/25 4:15:26 PM ET
    $ZVIA
    Beverages (Production/Distribution)
    Consumer Staples

    $RDHL
    $RDWR
    $SILV
    $SNES
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    FDA Approval for ZIMHI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug ZIMHI (ORIG-1) with active ingredient NALOXONE HYDROCHLORIDE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 212854, Application Classification: Type 5 - New Formulation or New Manufacturer

    10/18/21 11:55:40 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SYMJEPI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug SYMJEPI (SUPPL-12) with active ingredient EPINEPHRINE has changed to 'Approval' on 06/29/2021. Application Category: NDA, Application Number: 207534, Application Classification: Labeling

    6/30/21 5:11:48 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $RDHL
    $RDWR
    $SILV
    $SNES
    Financials

    Live finance-specific insights

    View All

    Zevia Announces Third Quarter 2025 Results

    Q3 Net Sales Up 12.3%, led by volume growth Exceeds Net Sales and Adj. EBITDA guidance Zevia PBC ("Zevia" or the "Company") (NYSE:ZVIA), the Company bringing naturally delicious, zero sugar, clean-label beverages, today reported results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Net sales grew 12.3% to $40.8 million Gross profit margin was 45.6%, a reduction of 3.5 percentage points year over year Net loss was $2.8 million, including $0.9 million of non-cash equity-based compensation expense Loss per share was $0.04 to Zevia's Class A Common stockholders Adjusted EBITDA loss of $1.7 million(1) "Our strong performance in the third quarter, hi

    11/5/25 4:05:00 PM ET
    $ZVIA
    Beverages (Production/Distribution)
    Consumer Staples

    Cytokinetics Reports Third Quarter 2025 Financial Results and Provides Business Update

    Interactions with FDA Progressing Towards December 26, 2025 PDUFA Date for Aficamten; U.S. Commercial Launch Preparations on Track Ex-U.S. Regulatory Reviews of Aficamten Ongoing in China and E.U. ~$1.25 Billion in Cash, Cash Equivalents and Investments as of September 30, 2025 SOUTH SAN FRANCISCO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) reported a management update and financial results for the third quarter of 2025. "I'm pleased that our teams continue to demonstrate strong execution and sustained momentum as we approach the PDUFA date for the aficamten NDA. Our commercial preparations have been deliberate and strategic, positioning us well

    11/5/25 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Inogen Announces Third Quarter 2025 Financial Results

    Delivered seventh consecutive quarter of mid-single-digit revenue growth Reiterating full-year revenue guidance Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30, 2025. Recent Highlights $92.4 million revenue, a year-over-year increase of 4.0%, marking the seventh consecutive quarter of mid-single-digit percentage growth GAAP net loss of $5.3 million and adjusted net loss of $0.5 million compared to prior year GAAP net loss of $6.0 million and adjusted net loss of $2.6 million $2.3 million adjusted EBITDA, the third consecutive quart

    11/5/25 7:30:00 AM ET
    $INGN
    Industrial Specialties
    Health Care

    $RDHL
    $RDWR
    $SILV
    $SNES
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/13/24 9:05:42 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/13/24 5:07:48 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    SEC Form SC 13G filed by PSQ Holdings Inc.

    SC 13G - PSQ Holdings, Inc. (0001847064) (Subject)

    12/12/24 11:50:43 AM ET
    $PSQH
    Advertising
    Consumer Discretionary

    $RDHL
    $RDWR
    $SILV
    $SNES
    Leadership Updates

    Live Leadership Updates

    View All

    Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director

    King of Prussia, Pennsylvania--(Newsfile Corp. - October 31, 2025) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio is pleased to announce that David Deming has been appointed Lead Independent Director of the Board of Directors of Phio Pharmaceuticals. Mr. Deming brings over 30 years of experience in investment banking and asset management to his new role as Lead Independent Director. He was with JP Morgan for over 27 years, both in M&A and leading the Health Group in investment banking for his last 12 years there. Mr. Deming was appointed

    10/31/25 10:15:00 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SunPower Executes Major Sales Force Expansion Following Sunder Merger

    OREM, Utah, Oct. 30, 2025 (GLOBE NEWSWIRE) -- SunPower Inc. (NASDAQ:SPWR) a solar technology, services, and installation company, this morning announced the successful integration of the Sunder salesforce into the company — as SunPower continues to execute on plan and expects to achieve record revenue of $83.3 million and record operating income of $3.5 million in Q4 2025. Eric Nielsen, SunPower's EVP of Sales said, "I am happy to report the integration of Sunder's salesforce into SunPower has been seamless and as a result, has enabled our team to continue to execute on plan without missing a beat. In addition, this deal has been well received across the industry — evidenced by the fact t

    10/30/25 8:00:00 AM ET
    $CSLR
    $SPWR
    Semiconductors
    Technology

    Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series

    Registration Link Below for October 28, 2025 12 PM EST Presentation and Live Q&AKing of Prussia, Pennsylvania--(Newsfile Corp. - October 21, 2025) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present an update on the company's proprietary INTASYL siRNA technology and progress on the on-going clinical trial with lead compound PH-762 for treatment of skin cancers. Recently, positive interim safety and efficacy results were reported in the o

    10/21/25 7:45:00 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care